CorMedix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	470	475	186	163	152	195
Market Cap Growth	-24.42%	154.71%	14.40%	6.98%	-21.92%	17.30%
Enterprise Value	549	431	109	108	90	166
Last Close Price	5.80	7.70	3.42	3.66	3.88	5.95
PS Ratio	2.57	11.31	-	2662.04	907.08	997.29
PB Ratio	1.47	5.81	2.94	3.16	2.76	5.40
P/TBV Ratio	-	5.94	2.94	3.16	2.76	5.40
EV/Sales Ratio	3.02	10.26	-	1772.75	535.14	846.85
Debt / Equity Ratio	0.40	0.01	0.01	0.02	0.02	0.02
Net Debt / Equity Ratio	0.25	-0.60	-1.07	-1.05	-1.03	-1.02
Net Debt / EBITDA Ratio	0.86	2.32	1.54	1.90	2.20	1.67
Net Debt / FCF Ratio	1.25	1.01	1.95	2.36	2.86	2.05
Asset Turnover	0.52	0.43	-	0.00	0.00	0.01
Inventory Turnover	0.69	0.66	-	-	2.03	0.85
Quick Ratio	1.60	3.05	6.67	9.32	12.26	11.14
Current Ratio	1.94	3.39	6.97	9.44	12.44	11.58
Return on Equity (ROE)	75.09%	-23.16%	-74.02%	-50.40%	-52.72%	-64.91%
Return on Assets (ROA)	15.68%	-13.91%	-42.47%	-29.23%	-31.12%	-43.19%
Return on Capital Employed (ROCE)	16.80%	-26.30%	-69.30%	-55.00%	-46.30%	-60.30%
Earnings Yield	29.46%	-3.65%	-22.49%	-17.06%	-16.29%	-9.23%
FCF Yield	13.49%	-10.32%	-18.80%	-14.12%	-13.04%	-9.25%
Buyback Yield / Dilution	-24.69%	-15.65%	-26.39%	-6.93%	-31.87%	-18.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.